本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Hepion Pharmaceuticals, Inc.

0.0688
+0.00487.50%
成交量:3,516.00
成交额:240.25
市值:75.51万
市盈率:0.00
高:0.0688
开:0.0688
低:0.0602
收:0.0640
数据加载中...
2025/01/14

SEC问询函

Form CORRESP - Correspondence
2025/01/14

SEC问询函

Form CORRESP - Correspondence
2025/01/14

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/01/13

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/12/26

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/12/11

重要事件披露

Form 8-K - Current report
2024/11/21

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2024/11/21

重要事件披露

Form 8-K - Current report
2024/11/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/09/05

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2024/09/05

重要事件披露

Form 8-K - Current report
2024/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/07

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2024/08/07

重要事件披露

Form 8-K - Current report
2024/07/22

重要事件披露

Form 8-K - Current report
2024/07/22

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2024/07/12

SEC问询函

Form CORRESP - Correspondence
2024/07/11

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/06/25

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]